• Adapting Biopharma to AI: A 2024 Update with Greg Meyers

  • Aug 27 2024
  • Duração: 26 minutos
  • Podcast

Adapting Biopharma to AI: A 2024 Update with Greg Meyers

Ouça grátis

Ver detalhes do programa

  • Sumário

  • Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb, or BMS, joins Jorge Conde, general partner at a16z.

    This is a follow-up to their 2023 episode, where they discussed how biopharma can adapt to AI. Now, they revisit the conversation to see what’s changed and what hasn’t.

    Together, they chat through tech as a competitive differentiator for large companies, generative AI for drug development, and what Greg and BMS look for in potential partners. They also highlight the importance of being agile and adaptable while navigating the changing landscape of biotech, providing valuable insights for founders.
    Exibir mais Exibir menos
Ciências
Exibir mais Exibir menos
activate_samplebutton_t1

O que os ouvintes dizem sobre Adapting Biopharma to AI: A 2024 Update with Greg Meyers

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.

Avaliações Audible.com.br

Avaliações na Amazon
Nenhuma revisão disponível